Idiopathic Thrombocytopenic Purpura (ITP) News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Link Between CVD Risk and Idiopathic Thrombocytopenic Purpura Examined - The Cardiology Advisor



The Cardiology Advisor
 
Link Between CVD Risk and Idiopathic Thrombocytopenic Purpura Examined 
The Cardiology Advisor
HealthDay News ? There is an increased risk of developing cardiovascular disease (CVD) in patients with idiopathic thrombocytopenic purpura (ITP), especially those who undergo splenectomy, according to a study published online in the Journal of ...

 


Diagnosing Idiopathic Thrombocytopenia Purpura - OncLive



OncLive
 
Diagnosing Idiopathic Thrombocytopenia Purpura 
OncLive
Keith R. McCrae, MD: One thing I would add is that we didn't mention drug-induced thrombocytopenia, which some people would consider as a form of secondary ITP. People ask, ?What drugs can cause thrombocytopenia?? I say, ?What drugs can't?? We clearly ...

and more » 


Understanding the Pathophysiology of ITP - OncLive



OncLive
 
Understanding the Pathophysiology of ITP 
OncLive
Ivy Altomare, MD: Thank you for joining us for this OncLiveŽ Peer ExchangeŽ program on adult idiopathic thrombocytopenia purpura (ITP). I'm Dr. Ivy Altomare, an associate professor of medicine at Duke University Medical Center. Joining me for this ...

and more » 


Idiopathic thrombocytopenic purpura tied to higher CVD risk - Medical Xpress



Medical Xpress
 
Idiopathic thrombocytopenic purpura tied to higher CVD risk 
Medical Xpress
The elevated risk of developing CVD in the ITP cohort (adjusted incidence rate ratio [IRR], 1.38) remained even after a sensitivity analysis which included only incident cases of ITP. The risk of developing CVD was further elevated among patients who ...
Are Patients With ITP at Increased Risk for Cardiovascular Disease? Monthly Prescribing Reference

all 1 news articles » 


Dova Pharmaceuticals Provides Update on Development Strategy for Avatrombopag in Immune Thrombocytopenic ... - GlobeNewswire (press release)



Dova Pharmaceuticals Provides Update on Development Strategy for Avatrombopag in Immune Thrombocytopenic ... 
GlobeNewswire (press release)
DURHAM, N.C., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Following two separate meetings with the U.S. Food and Drug Administration (FDA), Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) plans to submit a Supplemental New Drug Application (sNDA) in the second half of ...

and more » 


Promacta receives Breakthrough Therapy designation for SAA - European Pharmaceutical Review



European Pharmaceutical Review
 
Promacta receives Breakthrough Therapy designation for SAA 
European Pharmaceutical Review
Eltrombopag, marketed as Promacta in the United States and Revolade in countries outside the US, is approved in more than 100 countries worldwide for the treatment of thrombocytopenia in adult patients with chronic immune (idiopathic) thrombocytopenic ...

and more » 


Immunoglobulin Market Reach $13,619 Million by 2023 ? The Daily ... - The Daily Telescope



Immunoglobulin Market Reach $13,619 Million by 2023 ? The Daily ... 
The Daily Telescope
Portland, OR -- 01/15/2018 -- Immunoglobulins (IGs) are glycoproteins produced in the blood plasma in response to the antigens, which are foreign to the host system. They are highly complex entities and specific in their action. They are obtained from ...

and more » 


DAISY program honors nurses - Geneseo Republic



Geneseo Republic
 
DAISY program honors nurses 
Geneseo Republic
Wolf said, ?We are proud to be among the healthcare organizations participating in the DAISY Award program. Nurses are heroes every day. It's important that our nurses know their work is highly valued, and The DAISY Foundation provides a way for us to ...

 


McLeod nurse Jennifer Morris receives DAISY Award | Health ... - SCNow



SCNow
 
McLeod nurse Jennifer Morris receives DAISY Award | Health ... 
SCNow
FLORENCE, S.C. ? Registered Nurse Jennifer Morris was named the first DAISY Award recipient for McLeod Regional Medical Center on Thursday.

and more » 


Jane Whiteley named 2017 DAISY winner - Jacksonville Daily Progress



Jacksonville Daily Progress
 
Jane Whiteley named 2017 DAISY winner 
Jacksonville Daily Progress
Patrick died at the age of 33 in late 1999 from complications of Idiopathic Thrombocytopenic Purpura (ITP), a little known but not uncommon auto-immune disease. The care Patrick and his family received from nurses while he was ill inspired this unique ...